NCT00210509View on ClinicalTrials.gov

A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache

PHASE4CompletedINTERVENTIONAL

Enrollment

378

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

June 30, 2005

Conditions

Migraine

Interventions

DRUG

almotriptan malate

All Listed Sponsors

collaborator

Ortho-McNeil Neurologics, Inc.

INDUSTRY

lead

Janssen-Ortho LLC

INDUSTRY

NCT00210509 - A Study of the Effectiveness and Safety of Almotriptan Versus Placebo in the Treatment of Migraine Headache | Biotech Hunter | Biotech Hunter